Cytotoxic and Pathogenic Properties of Klebsiella oxytoca Isolated from Laboratory Animals

Klebsiella oxytoca is an opportunistic pathogen implicated in various clinical diseases in animals and humans. Studies suggest that in humans K. oxytoca exerts its pathogenicity in part through a cytotoxin. However, cytotoxin production in animal isolates of K. oxytoca and its pathogenic properties have not been characterized. Furthermore, neither the identity of the toxin nor a complete repertoire of genes involved in K. oxytoca pathogenesis have been fully elucidated. Here, we showed that several animal isolates of K. oxytoca, including the clinical isolates, produced secreted products in bacterial culture supernatant that display cytotoxicity on HEp-2 and HeLa cells, indicating the ability to produce cytotoxin. Cytotoxin production appears to be regulated by the environment, and soy based product was found to have a strong toxin induction property. The toxin was identified, by liquid chromatography-mass spectrometry and NMR spectroscopy, as low molecular weight heat labile benzodiazepine, tilivalline, previously shown to cause cytotoxicity in several cell lines, including mouse L1210 leukemic cells. Genome sequencing and analyses of a cytotoxin positive K. oxytoca strain isolated from an abscess of a mouse, identified genes previously shown to promote pathogenesis in other enteric bacterial pathogens including ecotin, several genes encoding for type IV and type VI secretion systems, and proteins that show sequence similarity to known bacterial toxins including cholera toxin. To our knowledge, these results demonstrate for the first time, that animal isolates of K. oxytoca, produces a cytotoxin, and that cytotoxin production is under strict environmental regulation. We also confirmed tilivalline as the cytotoxin present in animal K. oxytoca strains. These findings, along with the discovery of a repertoire of genes with virulence potential, provide important insights into the pathogenesis of K. oxytoca. As a novel diagnostic tool, tilivalline may serve as a biomarker for K oxytoca-induced cytotoxicity in humans and animals through detection in various samples from food to diseased samples using LC-MS/MS. Induction of K. oxytoca cytotoxin by consumption of soy may be in part involved in the pathogenesis of gastrointestinal disease.

[1]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[2]  A. Reyes,et al.  Soybean Meal Induces Intestinal Inflammation in Zebrafish Larvae , 2013, PloS one.

[3]  M. L. Fernández-Murga,et al.  Duodenal-Mucosal Bacteria Associated with Celiac Disease in Children , 2013, Applied and Environmental Microbiology.

[4]  S. Coulthurst,et al.  The Type VI secretion system - a widespread and versatile cell targeting system. , 2013, Research in microbiology.

[5]  A. Nowak‐Wegrzyn,et al.  Manifestations, diagnosis, and management of food protein-induced enterocolitis syndrome. , 2013, Pediatric annals.

[6]  Christopher L. Johnson,et al.  The unstructured domain of colicin N kills Escherichia coli , 2013, Molecular microbiology.

[7]  B. Bochner,et al.  Using Phenotype MicroArrays to Determine Culture Conditions That Induce or Repress Toxin Production by Clostridium difficile and Other Microorganisms , 2013, PloS one.

[8]  Danny S. Park,et al.  Campylobacter jejuni Type VI Secretion System: Roles in Adaptation to Deoxycholic Acid, Host Cell Adherence, Invasion, and In Vivo Colonization , 2012, PloS one.

[9]  M. Al-Abbadi,et al.  Chronic organizing retroperitoneal abscess caused by Klebsiella oxytoca masquerading as sarcoma: Recognition by Diff–Quik stain on FNA material , 2012, Diagnostic cytopathology.

[10]  A. Müller.  Multistep activation of the Helicobacter pylori effector CagA. , 2012, The Journal of clinical investigation.

[11]  D. Di Gioia,et al.  Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants , 2011, BMC Microbiology.

[12]  J. Horcajada,et al.  Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  S. Griffey,et al.  Opportunistic Bacterial Infections in Breeding Colonies of the NSG Mouse Strain , 2011, Veterinary pathology.

[14]  O. Szenci,et al.  Outbreak of Klebsiella oxytoca enterocolitis on a rabbit farm in Hungary , 2011, Veterinary Record.

[15]  F. Mégraud,et al.  First Report of Septic Arthritis Caused by Klebsiella oxytoca , 2010, Journal of Clinical Microbiology.

[16]  J. A. Cole,et al.  Modulation of Shigella virulence in response to available oxygen in vivo , 2010, Nature.

[17]  A. Deutschmann,et al.  Antibiotic-Associated Hemorrhagic Colitis Caused by Cytotoxin-Producing Klebsiella oxytoca , 2010, Pediatrics.

[18]  T. Hinterleitner,et al.  Cytotoxic Effects of Klebsiella oxytoca Strains Isolated from Patients with Antibiotic-Associated Hemorrhagic Colitis or Other Diseases Caused by Infections and from Healthy Subjects , 2010, Journal of Clinical Microbiology.

[19]  R. Calabrese,et al.  Molecular identification of coliform bacteria from colicky breastfed infants , 2009, Acta paediatrica.

[20]  Z. Shen,et al.  Chronic Hepatitis, Hepatic Dysplasia, Fibrosis, and Biliary Hyperplasia in Hamsters Naturally Infected with a Novel Helicobacter Classified in the H. bilis Cluster , 2009, Journal of Clinical Microbiology.

[21]  G. Gorkiewicz.  Nosocomial and antibiotic-associated diarrhoea caused by organisms other than Clostridium difficile. , 2009, International journal of antimicrobial agents.

[22]  T. Hinterleitner,et al.  Role of Klebsiella oxytoca in antibiotic-associated diarrhea. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  K. Al-Anazi,et al.  Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports , 2008, Cases journal.

[24]  Shaohua Zhao,et al.  Campylobacter-Induced Interleukin-8 Secretion in Polarized Human Intestinal Epithelial Cells Requires Campylobacter-Secreted Cytolethal Distending Toxin- and Toll-Like Receptor-Mediated Activation of NF-κB , 2008, Infection and Immunity.

[25]  J. Sundberg,et al.  Klebsiella oxytoca: opportunistic infections in laboratory rodents , 2008, Laboratory animals.

[26]  M. S. Murphy.  Management of bloody diarrhoea in children in primary care , 2008, BMJ : British Medical Journal.

[27]  A. Gales,et al.  Outbreak of OXY-2-Producing Klebsiella oxytoca in a Renal Transplant Unit , 2008, Journal of Clinical Microbiology.

[28]  Jos Boekhorst,et al.  Identification of homologs in insignificant blast hits by exploiting extrinsic gene properties , 2007, BMC Bioinformatics.

[29]  C. Langner,et al.  Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. , 2006, The New England journal of medicine.

[30]  Y. Boum,et al.  Environmental signals implicated in Dr fimbriae release by pathogenic Escherichia coli. , 2006, Microbes and infection.

[31]  G. Ya. Wiederschain,et al.  The proteomics protocols handbook , 2006, Biochemistry (Moscow).

[32]  L. Holm,et al.  The Pfam protein families database , 2005, Nucleic Acids Res..

[33]  H. Chou,et al.  Isolation of a Chromosomal Region of Klebsiella pneumoniae Associated with Allantoin Metabolism and Liver Infection , 2004, Infection and Immunity.

[34]  A. G. Day,et al.  The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase. , 2004, The Biochemical journal.

[35]  S. Brisse,et al.  Identification of Klebsiella oxytoca using a specific PCR assay targeting the polygalacturonase pehX gene. , 2003, Research in microbiology.

[36]  S. Yamasaki,et al.  Cloning and Characterization of Genes Encoding Homologues of the B Subunit of Cholera Toxin and the Escherichia coli Heat-Labile Enterotoxin from Clinical Isolates of Citrobacter freundii and E. coli , 2002, Infection and Immunity.

[37]  Z. Shen,et al.  Novel Helicobacter species isolated from rhesus monkeys with chronic idiopathic colitis. , 2001, Journal of medical microbiology.

[38]  J. Fox,et al.  Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. , 2000, Journal of medical microbiology.

[39]  P. Kuhnert,et al.  Characterization of PaxA and Its Operon: a Cohemolytic RTX Toxin Determinant from Pathogenic Pasteurella aerogenes , 2000, Infection and Immunity.

[40]  Yuji Koseki,et al.  Stereoselective Synthesis of Tilivalline(1). , 1998, The Journal of organic chemistry.

[41]  R. Podschun,et al.  Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors , 1998, Clinical Microbiology Reviews.

[42]  L. Bermudez,et al.  Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells , 1997, Infection and immunity.

[43]  P. Hsueh,et al.  Bacteremia due to Klebsiella oxytoca: clinical features of patients and antimicrobial susceptibilities of the isolates. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  D. Pierson,et al.  Ail expression in Yersinia enterocolitica is affected by oxygen tension , 1995, Infection and immunity.

[45]  T. Shioiri,et al.  Wide difference between the cytotoxicity of the 11-α- and 11-β-cyano analogues of tilivalline and their epimeric conversion , 1995 .

[46]  T. Shioiri,et al.  Structure-cytotoxicity relationship of tilivalline derivatives. , 1995, Anti-cancer drug design.

[47]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Yoshida,et al.  Biological activities and chemical composition of a cytotoxin of Klebsiella oxytoca. , 1992, Journal of general microbiology.

[49]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[50]  H. Hayashi,et al.  Production of a unique cytotoxin by Klebsiella oxytoca. , 1989, Microbial pathogenesis.

[51]  J. Lindsey,et al.  The role of Klebsiella oxytoca in utero-ovarian infection of B6C3F1 mice. , 1987, Laboratory animal science.

[52]  Rao Gn,et al.  Utero-ovarian infection in aged B6C3F1 mice. , 1987 .

[53]  S. J. Campbell,et al.  A study of the prevalence of cytotoxic and non-cytotoxic Klebsiella oxytoca fecal colonization in two patient populations. , 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[54]  John M. Walker,et al.  The Proteomics Protocols Handbook , 2005, Humana Press.

[55]  T. Shioiri,et al.  Wide difference between the cytotoxicity of the 11-alpha-and 11-beta-cyano analogues of tilivalline and their epimeric conversion. , 1995, Biochemical pharmacology.

[56]  S. Seilkop,et al.  Utero-ovarian infection in aged B6C3F1 mice. , 1987, Laboratory animal science.

[57]  H. Budzikiewicz,et al.  Tilivalline, a new pyrrolo[2, 1-c][1,4] benzodiazepine metabolite from klebsiella , 1982 .